The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
36
No.
33
September 17, 2010
- ASCO Proposes Two IOM Workshops On Changing Clinical Trials Group System
- Duke Comprehensive Cancer Center Wins Core Grant Renewal
- Stand Up To Cancer Says $80 Million in Pledges Raised
- Cell Therapeutics To Appeal FDA Decision on Pixantrone.
- ASTRO Announces Election Results, Staff Restructuring
- Brenner To Leave Breast Cancer Action
- Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI
TCL
Vol.
36
No.
34
September 24, 2010
- Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says
- National Breast Cancer Coalition Sets Goal To End Breast Cancer By Jan. 1, 2020
- FDA Delays Decision On Avastin Approval For Breast Cancer
- MD Anderson Completes $500 Million Research Endowment
- NIH Biennial Report Offers Research Portrait
- Gulf Health Study Begun With $10 Million Each from NIH, BP
CCL
Vol.
33
No.
9
September 24, 2010
- New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial
- Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too
- Rituximab Prolonged Survival Of CLL In Phase III Study
- A Low-Cost Vaccine To Enter Clinical Trials In A Year
- HPV DNA Testing Reduced Cervical Cancer Precursors
- Targeting Men At High Risk Finds More Head & Neck Cancer
- Half Of Mexican-Origin Women With Breast Cancer Diagnosed Before Age 50, Study Finds
- Multivitamin Use Doesn’t Impact Outcomes, Study Finds
- NCI Cooperative Group Clinical Trials Approved
TCL
Vol.
36
No.
35
October 01, 2010
- An Impromptu Group Proposes Standards For Publication Of Genomics Research
- IOM To Form Committee To Investigate Duke Genomics Research
- University of Pittsburgh Cancer Institute Wins Core Grant Renewal
- NCI STRAP Grants Aim To Move Research Quickly To Clinical Trials
- CMS, FDA Developing Process For Concurrent Therapy ApprovalsAACI To Honor Mary-Claire King, Sen. Sherrod Brown
- NIH Clinical Center Offers Sabbatical In Clinical Research Management
TCL
Vol.
36
No.
36
October 08, 2010
- New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing
- Protocol Amendments Required For 98 NCI-Sponsored Trials
- Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing
- FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate
- Nobel In Chemistry For Work Linking Carbon Atoms
- Genentech’s Ferrara Wins Lasker Award For VEGF Discovery
- Obituary: Ben Horowitz, 96, Led City of Hope For 32 Years
- New NIH Grant Program or Young Investigators
TCL
Vol.
36
No.
37
October 15, 2010
- Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs
- Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?
- Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing
- Hutchinson Center Receives NCI Grant For Immunotherapy Network
- Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch
- Research Teams Win Honors For Cancer Immunotherapy Work
TCL
Vol.
36
No.
38
October 22, 2010
- IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria
- NCI Sends A Second Letter To Groups About Carboplatin
- Agency Asks GnRH Sponsors To Add Warnings On Labels
- NCI Awards STRAP Grant Of $2 Million To MSKCC
- Beth Israel Suspends Enrollment In Trials Following An Audit
- NCCN Guidelines Retain Avastin For Breast Cancer
- FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers
- “Dollars For Docs” Database Of Pharma Payments Posted By News Organization
TCL
Vol.
36
No.
39
October 29, 2010